Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk announces FDA approval for Levemir
Yahoo/Fly on the Wall
Monday, April 2, 2012 - 12:03pm
tags:
FDA, pregnancy, Levemir, diabetes, Novo Nordisk
Novo Nordisk to move forward with once-weekly diabetes shot, Bloomberg says
Yahoo/Fly on the Wall
Monday, April 2, 2012 - 12:02pm
tags:
Novo Nordisk, diabetes, Victoza
Merck: Now A Compelling 'Buy' Candidate
Seeking Alpha
Monday, April 2, 2012 - 11:58am
tags:
Merck, M&A, Bayer, GSK, Pfizer
Sanofi buys U.S. animal vaccine firm
Reuters
Monday, April 2, 2012 - 11:56am
tags:
M&A, animal health, Sanofi, Newport Laboratories
Forest buys hypertension drug rights from J&J
Reuters
Monday, April 2, 2012 - 10:50am
tags:
Forest, JNJ, antihypertensives, Bystolic
GlaxoSmithKline Boosts Stake in Theravance
TheStreet.com
Monday, April 2, 2012 - 10:45am
tags:
GSK, Theravance
Keryx: Perifosine Colon Cancer Trial Fails
TheStreet.com
Monday, April 2, 2012 - 10:44am
tags:
perifosine, colon cancer, Keryx, Aeterna Zentaris
Ranbaxy starts generic Lipitor shipments from India
Reuters
Monday, April 2, 2012 - 10:43am
tags:
Lipitor, generics, Pfizer, Ranbaxy
Novartis Says Smoker’s-Cough Drug Succeeded in Trials
Bloomberg
Monday, April 2, 2012 - 10:43am
tags:
smoker's cough, Novartis, QVA149, Arcapta Neohaler, Seebri Breezhaler
Merrimack IPO Falls Out Of The Gate
Seeking Alpha
Monday, April 2, 2012 - 10:41am
tags:
Merrimack Pharmaceuticals, IPOs
Are Ariad's Options Dwindling?
Motley Fool
Sunday, April 1, 2012 - 12:35pm
tags:
Ariad Pharmaceuticals, ridaforolimus, Merck, GSK, Votrient
Coronado Biosciences: Provides Investors With 2 Distinct Pipelines And Significant Market Potential
Seeking Alpha
Sunday, April 1, 2012 - 12:18pm
tags:
Coronado Biosciences, Crohn's Disease, ulcerative colitis, multiple sclerosis, OvaMed, CNDO-109, acute myeloid leukemia
Drug for rare disease may lift AVI BioPharma shares: Barron's
Yahoo/Reuters
Sunday, April 1, 2012 - 12:14pm
tags:
AVI BioPharma, eteplirsen, muscular dystrophy
Affymax's Anemia Drug Will Create Added Competition For Amgen
Seeking Alpha
Sunday, April 1, 2012 - 12:12pm
tags:
Affymax, Amgen, Omontys, anemia
Roche May Abandon its Bid for Illumina, SonntagsZeitung Reports
Bloomberg
Sunday, April 1, 2012 - 12:10pm
tags:
Roche, Illumina, M&A
Abbott's Game-Changing PLEX-ID Receives CE Mark
Seeking Alpha
Sunday, April 1, 2012 - 12:03pm
tags:
Abbott Laboratories, PLEX-ID
Johnson & Johnson's CEO-in-waiting, an insider, yes, but also a capable leader, allies say.
The Star Ledger, NJ
Sunday, April 1, 2012 - 12:01pm
tags:
JNJ
China Biotech In Review: GE Seeks To Increase China Revenues By Expanding Beyond Top Tier Markets
Seeking Alpha
Sunday, April 1, 2012 - 11:46am
tags:
Chongqing Huapont Pharma, RegeneRx, GSK, Hanmi Pharma, Hubei Minkang Pharma, Bayer, GE Healthcare, Roche
9 Undervalued Healthcare Stocks With Strong Hedge Fund Buying
Seeking Alpha
Sunday, April 1, 2012 - 11:43am
tags:
Akorn, Depomed, Cigna, Elan, PDL Biopharma, Questcor Pharmaceuticals, USANA Health Sciences, Transcend Medical, Sun Healthcare Group
Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis
Pipeline Review
Saturday, March 31, 2012 - 1:11pm
tags:
Raptor Pharmaceuticals, RP103, nephropathic cystinosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.